Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)

Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)

Penson PE, Bruckert E, Marais D, Reiner Ž, Pirro M, Sahebkar A, Bajraktari G, Mirrakhimov E, Rizzo M, Mikhailidis DP, Sachinidis A, Gaita D, Latkovskis G, Mazidi M, Toth PP, Pella D, Alnouri F, Postadzhiyan A, Yeh HI, Mancini GBJ, von Haehling S, Banach M; International Lipid Expert Panel (ILEP).

Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)

Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)

Massimiliano Ruscica, Peter E Penson, Nicola Ferri, Cesare R Sirtori, Matteo Pirro, G B John Mancini, Naveed Sattar, Peter P Toth, Amirhossein Sahebkar, Carl J Lavie, Nathan D Wong, Maciej Banach; International Lipid Expert Panel (ILEP) and International Lipid Expert Panel Experts (alphabetically)

Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies

Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies

Kamal Awad, Maged Mohammed, Mahmoud Mohamed Zaki, Abdelrahman I Abushouk, Gregory Y H Lip, Michael J Blaha, Carl J Lavie, Peter P Toth, J Wouter Jukema, Naveed Sattar, Maciej Banach; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group and the International Lipid Expert Panel (ILEP)